
mRNAã³ãããã¯ã¯ãã³ããå ¬è¡ã«æäžãããåã«ãå®å šã§ããããšã®ç§åŠç蚌æã¯ãªãã£ãããšããæ°ããç ç©¶ã§æããã«
å èšäºã¯ãã¡ããã/Click here to read the original article.
äžçä¿å¥äŒè°ïŒWCHïŒã®ä¿å¥ç§åŠå§å¡äŒã¯ãæè¿ãã³ãããã¯ã¯ãã³ãã«äœ¿çšãããmRNAãã©ãããã©ãŒã ã®æœåšçãªæå®³æ§ã«é¢ããè«æãçºè¡šããŸããã ãã®è«æã®èè
ã¯ãmRNAãã©ãããã©ãŒã ã¯åºæ¬çã«äœ¿çšã«äžé©åã§ããããããªã "ã¯ã¯ãã³ "ã«ãå®å
šã§ããããšã蚌æãããŠããªãããšãæããã«ããŸããã
ãã®è«æã¯ã3人ã®ç ç©¶è
ã«ãã£ãŠå·çããããã®ãã¡ã®1人ãTess Lawrieå士ã§ã2023幎4æ17æ¥ã«Multidisciplinary Scientific Journalèªã«æ²èŒãããŸããã
"æã
ã¯ãã®ã¬ãã¥ãŒãè¡ã£ã "ãšããŒãªãŒå士ã¯èª¬æããã"æã
ã¯ãã³ããã®ææãšäŒæãé²ãããšãç®çãšããå®çšåãšå€§éæäžã«å
ç«ã£ãŠããã®éåžžã«çãããã¯ã¯ãã³ããã©ãããã©ãŒã ã®å®å
šæ§ãå®èšŒããããã«ã©ã®ãããªç ç©¶ãè¡ãããããèŠããã£ãããã "3
çããæè¡ã䜿ã£ãçæ°ããè¬ãæäžãããæçšãããããåã«ã"ãã®çããæè¡ã®äœ¿çšãæ¯æããæ ¹æ ã¯äœããããã«äŒŽãæœåšçãªå®³ã¯äœãïŒ"ãšå°ããã®ã¯åŠ¥åœãªããšã§ãããã®åãã«çãããããç ç©¶è
ãã¡ã¯ç§åŠæç®ã«æ²èŒããããã®ã調ã¹ãŸããã ãã®è«æã¯ããã®æ°ããæè¡ã®çºå£²ã«ã€ãªãã£ãåºç€çãªç ç©¶ãéããè©äŸ¡ãããã®ã§ããç ç©¶è
ãã¡ã®ç¥ãéãããã®çš®ã®ã¬ãã¥ãŒãšããŠã¯åããŠã®ãã®ã§ãã
ãã®ã¬ãã¥ãŒã¯ãmRNAãã©ãããã©ãŒã ã«çŠç¹ãåœãŠãã³ãã "ã¯ã¯ãã³ "ã®ä»ã®æ§æèŠçŽ ã«ãã£ãŠåŒãèµ·ããããæœåšçãªå®³ãèæ
®ããŠããŸããã
"æã
ã¯ãmRNAãã©ãããã©ãŒã ã䜿çšããŠãéçºãããã³ãã "ã¯ã¯ãã³ãå®å
šã§ããããšã瀺åãã蚌æ ãäžçå±éåã«ååšããªãããšãçºèŠãã "ãšLawrieå士ã¯è¿°ã¹ãã
ã³ãããžã£ãã®äœãæªããŠããããªã«å€ãã®äººãå·ã€ããŠããã®ã§ããããã
WCHãã«ã¹ïŒãµã€ãšã³ã¹å§å¡äŒã¯ãæ°ããªç§åŠã®æåç·ã«ç«ã¡ç¶ããããšãç®æšãšããŠããŸããçæ§ã®ãæ¯æŽã«ãããæè¿çºè¡šããæ»èªä»ãç§åŠè«æãmRNAãŠã€ã«ã¹ã¯ã¯ãã³ã®æ°èŠæ§ãšæœåšçãªæå®³æ§ãã®å 容ãç¥ãããšãã§ããå¬ããæã£ãŠããŸãïŒ ãšããæ»èªä»ãè«æãçºè¡šããŸããã
ãã®åŸãäžè¬ã®æ¹ã ããããã®ç§åŠè«æã®çµæãç°¡åã«èª¬æããŠã»ãããšããã¡ãŒã«ãã¡ãã»ãŒãžãããã€ãããã ããŸããã®ã§ããã®èšäºã§ã¯ããã®ãããªèª¬æãããããšã«åªããŸãã
ãŸããåœéçãªãã¡ãŒãã³ããžã©ã³ã¹ã»ããŒã¿ããŒã¹ïŒå»è¬åã®å¯äœçšãèšé²ããããŒã¿ããŒã¹ïŒããã³ããã19ã®æ³šå°ã«ãã£ãŠæªåœ±é¿ãåããããŸããŸãªæªãåå¿ãèµ·ãããŠãã人ã ã®æ°ã®å€ãã«èŠéã鳎ãããŠããããšã§ããæ¬¡ã«ãã¯ã¯ãã³ã®å®³ã«é¢ããç§åŠè«æã§ã¯ã害ãåŒãèµ·ããã¡ã«ããºã ãšããŠã¹ãã€ã¯ã¿ã³ãã¯è³ªãææããåŸåããããŸãã
ç§ãã¡ããã®ã¬ãã¥ãŒãè¡ã£ãã®ã¯ããã®éåžžã«çãããã¯ã¯ãã³ããã©ãããã©ãŒã ã®å®å šæ§ãå®èšŒããããã«ãã³ããã®ææãšäŒæãé²ãç®çã§å®çšåãã倧éæäžãããåã«ãã©ã®ãããªç ç©¶ãè¡ããããã確èªãããã£ãããã§ãã
ç§åŠæç®ã調æ»ããçµæãmRNAãã©ãããã©ãŒã ãå®å šã§ãªãå¯èœæ§ãããããã€ãã®çç±ã倿ããŸããïŒ
ããªãšãã¬ã³ã°ãªã³ãŒã«ïŒä»¥äžãPEGïŒã«ã¢ã¬ã«ã®ãŒãæã€äººãããããšã¯ãã§ã«ç¥ãããŠãããmRNAãã©ãããã©ãŒã ã¯ã身äœã®èªç¶å ç«ã·ã¹ãã ãåé¿ããããã«ãPEGãå«ãè質ããç²åïŒLNPïŒã«äŸåããŠããŸããPEGã«ã¢ã¬ã«ã®ãŒã®ãã人ã«ã¯å±éºã§ããã ãã§ãªããç¹ã«ç¹°ãè¿ã泚å°ããããšã§ççãã¢ã¬ã«ã®ãŒåå¿ãåŒãèµ·ããå¯èœæ§ããããŸãã
mRNAã¯å®¿äž»çްèã®è£ 眮ã䜿ã£ãŠã¿ã³ãã¯è³ªãçæãããã®ã¿ã³ãã¯è³ªãæäœåå¿ãèµ·ããããšããããççãååºãèªå·±å ç«ã«é¢é£ããããšããããåŸè ã¯ãmRNAã«ãã£ãŠçްèå ã§äœãããç°ç©ã¿ã³ãã¯è³ªãšã®é¡äŒŒæ§ãããäœãèªåã®ã¿ã³ãã¯è³ªãéèªå·±ãšèªèããæ»æããããšã§èµ·ããã
ã³ãããŠã€ã«ã¹ã«å¯Ÿããã¯ã¯ãã³ã¯ãèšåºè©Šéšä»¥å€ã§äœ¿çšã§ããã»ã©å®å šæ§ã蚌æãããããšã¯ãªããç§ãã¡ã¯ãä»ã®ã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®ããå°èŠæš¡ãªèšåºè©Šéšã10件確èªããŸãããããããã¯ãã¹ãŠè©Šéšã®åææ®µéïŒãã§ãŒãºIãŸãã¯IIïŒã§ããããããã广ã蚌æãããŠããããæ°é±éãè¶ ããå®å šæ§ããŒã¿ããããŸããã§ããã
ã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã®åç©å®éšã§ã¯ãé«ãã¬ãã«ã®é節ãªå¯äœçšã瀺ããããã°ãã°å ç«ãç²åŸããããšãã§ããªãã£ãã
çç¬ç ãã€ã³ãã«ãšã³ã¶ããžã«ãŠã€ã«ã¹ãªã©ãã³ããã«å ç«ã¡ãã³ãã以å€ã®ãã¯ã¯ãã³ãçšéã§è©Šã¿ãããŠããRNAãã©ãããã©ãŒã ã¯ãå ¬è¡šããæ€èšŒå¯èœãªå®å šæ§ããŒã¿ãã»ãšãã©ãªããå©çšå¯èœãªããŒã¿ã§ã¯ãé節ãªå¯äœçšã®çºççãéåžžã«é«ãããšã瀺åãããŠããŸããç¹ã«RNAãã¯ã¯ãã³ãã«é¢ããŠã¯ãã³ããã19ãã¯ã¯ãã³ãã®è©Šéšåã«è¡ãããããã®ç ç©¶ã«ããã¯ã¯ãã³æ¥çš®ãç®çãšããmRNAãã©ãããã©ãŒã ã®äœ¿çšã«é¢ãã蚌æ ã®ç·èšã¯ãããã285人ã«éããŸããã
çããæè¡ã䜿ã£ãæ°è¬ãæäžãããæçšãããããåã«ã"ãã®çããæè¡ã®äœ¿çšãæ¯æããæ ¹æ ã¯äœããããã«äŒŽãæœåšçãªå®³ã¯äœãïŒ"ãšåãã®ã¯åŠ¥åœãªããšã§ãããã®åãã«çããããã«ãç§ãã¡ã¯ç§åŠæç®ã«çºè¡šããããã®ã調ã¹ãŸããã
ç§ãã¡ã®ç¥ãéãããã®çš®ã®ã¬ãã¥ãŒã®äžã§ãäžé©åã«ãã¯ã¯ãã³ããšåŒã°ãããã®æ°ããã¹ã¿ã€ã«ã®éºäŒåæ²»çæ³šå°ã®çºå£²ã«ã€ãªãã£ãåºç€ç ç©¶ãåéãè©äŸ¡ããæåã®ãã®ã®äžã€ã§ããæã ã¯ãç¹ã«mRNAãã©ãããã©ãŒã ãã®ãã®ã«çŠç¹ãåœãŠãã¯ã¯ãã³ã«ãã£ãŠèªçºãããã¿ã³ãã¯è³ªããééå±ãã°ã©ãã§ã³ãšãã£ããã¯ã¯ãã³ãã®ä»ã®æ§æèŠçŽ ã«ããæœåšçãªå®³ã¯åãäžããªãã£ãã
äžèšã§èšãã°ãmRNAã®ãã©ãããã©ãŒã ã䜿ã£ãŠéçºããã³ããã®ãã¯ã¯ãã³ããå®å šã§ããããšã瀺åãããšããã³ã¹ã¯ãäžçå±éåã«ã¯ååšããªãããšãããã£ãã®ã§ãã
mRNAã¯ã¯ãã³ã¯æçããæè¡ã§ãããšã¡ãŒã«ãŒãæèšããŠããã«ããããããããã¡ã€ã¶ãŒãšã¢ããã®äž¡æ¹ã®covid-19ãã¯ã¯ãã³ãã§äœ¿çšãããŠããååŠä¿®é£Ÿã§ããN1-methylpseudouridine修食RNAã®æãå€ãå®éšå®€å®éšã¯2015å¹Žãšæè¿ã®ãã®ã§ããã
ããããªãããã®ã¬ãã¥ãŒã®çµæã«ã·ã§ãã¯ãåããŠããã®ãªããããã¯åœç¶ã®ããšã§ããã³ããã-19泚å°ã«ãã£ãŠäººã ã被ã£ã害ã¯ããããŸã§ã®ç ç©¶ã«åºã¥ããŠäºæž¬ã§ãããã®ã§ããããšã¯æããã§ããå®éããžã¥ãã£ã»ãã³ãããå士ããªãŒã»ã¡ãªããå士ãªã©ãæ€é²ãåããå€ãã®ç§åŠè ãããããã®æ³šå°ãå±éããåã«äºæž¬ããŠããã®ã§ããã
ã¹ã³ãŒãã»ã¬ãã¥ãŒãšããŠãç§ãã¡ãæããã«ããããšã¯ãç¬ç«ããç§åŠè ãcovid-19ã®è©ŠéšããŒã¿ããã¡ãŒãã³ããžã©ã³ã¹ããŒã¿ããããŠé«åºŠã«å®éšçã§èšŒæãããŠããªããã©ãããã©ãŒã ã«åºã¥ãæ°ãããã¯ã¯ãã³ãã®ç·æ¥äœ¿çšèªå¯ãæ¥ãããäžçäžã®äžæ£ãªèŠå¶ããã»ã¹ã«ã€ããŠã¢ã¯ã»ã¹ã調æ»ããç·æ¥æ§ãå¿ èŠã§ãããšããããšã§ãããã®ãããªå±éºãªæ³šå°ãæ¢ããå¿ èŠãããããšã¯ãèšããŸã§ããããŸããã
ç§ãã¡ã®è«æã¯ããªãŒã¹ãã©ãªã¢ã®èåãªå ç«åŠè ã§ãããããŒãã»ã¯ã©ã³ã·ãŒåèªææãã¯ãããç§åŠçã®ã¡ã³ããŒãã奜è©ãåŸãŠããŸãïŒ
ããã¯ãã³ããæä»£ã®æèã§æžãããæãéèŠãªè«æã®1ã€ã§ãã
ãã®è«æã¯ãç£çãããæåã«çŠç¹ãåœãŠãã®ã§ã¯ãªããå ç«åå¿ãä¿é²ããç®çã§mRNAãééããããã©ãããã©ãŒã ãã®åºç¯ãªå®å šæ§åæãèŠæ±ããŠãããã»ãŒåç¬ã§æç«ããŠããŸãã285人ã®è¢«éšè ã«éãããããããªç¥èããæ°èŠæ²»çã«å¯Ÿããæ³šæãšæ éãã®é·ãæŽå²ã10ïŒ ãè¶ ããéå€§ãªæå®³äºè±¡ãå®å šæ§ã«é¢ããåæã®é転ã®èšé²ãšããæ çµã¿ã®äžã§ãŸãšãããšã忥çãæ¿æ²»çã«åæ©ã¥ããããã°ã«ãŒãïŒæ¥ããããªããç§ã®æ¿åºãå«ãïŒã«ããã¯ã¯ãã³æŠç¥ãæ°žé ã«å€ããããã®æ°ååãã«ã®mRNAããã°ã©ã 確ç«ãžã®åãçµã¿ãèŠçŽã説åŸåããããŸãã
æåŸã«ããã®ãããªå±éºãªæ³šå°ã®å®³ã®ã¡ã«ããºã ã«ã€ããŠã¯ãæ¥ã ãæããã«ãããŠããŸããç§ãã¡ã®ã¬ãã¥ãŒã¯ãmRNAãã©ãããã©ãŒã ã®ã¿ã®åŠ¥åœæ§ãæ€èšããã°ã©ãã§ã³ãééå±ãDNAïŒæ°ãã«ç¢ºèªãããæ±æç©è³ªïŒãªã©ãä»ã®ã³ãããã¯ã¯ãã³ãå 容ç©ã®å¯èœæ§ã«ããå®³ãæ€èšããªãã£ããšããç¹ã§éå®çã§ãã WCHãã«ã¹ïŒãµã€ãšã³ã¹å§å¡äŒãçºè¡šãã2ã€ã®æ°ããè«æã«ãããšããããã®æ°ãããã¯ã¯ãã³ãã®éºäŒç©è³ªããæ³šå°ãæã€ãã©ããã«ããããããç§ãã¡ã®äººéã®DNAã«çµã¿èŸŒãŸããå¯èœæ§ãéåžžã«é«ãããšã瀺åãããŠããŸãããã®ä»¶ã¯ãæšæ¥ã®ã©ã€ãã¹ããªãŒãã³ã°äŒè°ã§è°è«ããããã®é²ç»ã¯ãã¡ãã§ã芧ããã ããŸãã
ããã«è©³ããæ å ±ã«ã€ããŠã¯ãè±åœã®å»è¬åã»å»ç補åèŠå¶åºïŒMHRAïŒã®èŠå¶ããã»ã¹ã®å€±æã«é¢ãããã«ã»ãŠã¹ã®å ±åæžãããã³çç©å µåšãšããŠã®ã³ããæ³šå°ã®äºäŸã«é¢ããã«ã¬ã³ã»ãã³ã°ã¹ãã³ã®èª¬åŸåã®ããèšäºãã芧ãã ããã